Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice - News-Medical.Net
Researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike proteins of several SARS-CoV-2 variants.
In a recent study posted to the bioRxiv* preprint server, researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike (S) proteins of several severe a… [+6314 chars]
Read More
Other Stories in Health
- Stem-cell implants restore vision in patients with corneal stem cell deficiency
- Reducing In-Home Smoking: Practical Approaches for Primary Care Clinicians
- Johns Hopkins University MSN (Entry into Nursing) Spring 2025
- 7 benefits of eating a rainbow diet
- Study shows toddlers learn better from impossible events
- New model sheds light on APOE4's role in Alzheimer's pathology
- How calcium and magnesium deficiencies impact cognitive health
- Lincoln Memorial University CRNA 2025
- Heard of the 'UTI vaccine'? What you need to know about how it treats recurrent infections
.png)
